retatrutide type 2 diabetes Phase 2: Weight Loss and Key Trial Findings – Bolt Pharmacy Retatrutide—A Game Changer in Obesity
Description
By Drug Origin: Biosimilars Gain Ground Against Innovators Innovator brands commanded 64.05% of the South Korea diabetes drugs market share in 2025, but the biosimilar cohort is expanding at a 8.78% CAGR

5 This explains why TRIUMPH-4 produced 28.7% weight loss at 68 weeks while STEP-UP produced 20.7% at 72 weeks on Wegovy 7.2 mg, and STEP 1 produced 14.9% at 68 weeks on Wegovy 2.4 mg

Cook will help determine if ultrasound therapy, an alternative technology, or a combination approach best aligns with your goals

You're never alone on your journey thanks to scheduled check-ins and convenient access to expert advice

Keep away from children and away from direct sunlight

The medication is particularly effective when combined with basal insulin